Recruiting NA Robotic Surgical Procedures in Pediatric Urology

New treatment option for Robotic Surgical Procedures in Pediatric Urology

Official title Versius Paediatrics Study

ClinicalTrials.gov ID: NCT06539442

What this study is testing

What it's testing
This is prospective, multi-phase, single arm, multi-centre, multi-surgeon feasibility clinical trial to provide proof of concept and clinical evidence regarding the safety and efficacy of Versius (robotic surgery medical device) in Urological Procedures in Paediatric population. In alignment with IDEAL (Idea, Development, Exploration, Assessment, Long-term study) Framework, this study will consist of 3 main phases to ensure proper procedure development while ensuring patients safety.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 0 to 17

You may be able to join if

  • Patients, male or female, (\<18 years old) for whom an appropriate legal representative provides written consent for participation
  • Patient and disease factors deemed suitable for minimal access urological procedure
  • Multidisciplinary team (MDT) decision to treat with surgery
  • Patients under the care of the paediatric urology team in one of the participating centres

You likely can't join if

  • Patients ≥ 18 years old
  • Appropriate legal representative unwilling to provide written consent
  • Medical contraindication for general anaesthesia
  • Medical contraindication for laparoscopic procedure
  • Active pregnancy (in post-pubertal female patients)
  • Morbid obesity (BMI ≥ 40 kg/m2)
See the full eligibility criteria
Who can join
  • Patients, male or female, (\<18 years old) for whom an appropriate legal representative provides written consent for participation
  • Patient and disease factors deemed suitable for minimal access urological procedure
  • Multidisciplinary team (MDT) decision to treat with surgery
  • Patients under the care of the paediatric urology team in one of the participating centres
What rules you out
  • Patients ≥ 18 years old
  • Appropriate legal representative unwilling to provide written consent
  • Medical contraindication for general anaesthesia
  • Medical contraindication for laparoscopic procedure
  • Active pregnancy (in post-pubertal female patients)
  • Morbid obesity (BMI ≥ 40 kg/m2)
  • Patient participation in an treatment clinical study, that could impact primary objectives results
  • Prior pelvic /abdominal radiotherapy treatment
  • people with other clinically significant unstable medical disorder, life-threatening disease, or anything else in the opinion of the Investigator which would contra-indicate a surgical procedure

The study team makes the final eligibility decision.

Where it's taking place

  • London, United Kingdom
  • Manchester, United Kingdom
  • Southampton, United Kingdom

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 0 years to 17 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include London, United Kingdom; Manchester, United Kingdom; Southampton, United Kingdom. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.